Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others
Tags Pfizer Inc Johnson & Johnson Roche Holding AG
From CNBC.com News
Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground
Tags Healthy Returns LILLY DRN Health & Science
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Investment strategy Tesla Inc Investing
From CNBC.com News
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%
Tags Business Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition
Tags Novo Nordisk A/S Healthy Returns Health & Science
From CNBC.com News
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
Tags Health care industry CVS Health Corp Social issues
From CNBC.com News
Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly
Tags Business Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk CEO to step down as competition weighs on Wegovy maker's share price
Tags Europe News Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Denmark's economy is booming on drug exports — Trump's tariffs threat won't slow it down
Tags Politics Novo Nordisk A/S Europe Politics
From CNBC.com News
Why Americans pay so much more for prescription drugs
Tags Novo Nordisk A/S Politics LILLY DRN
From CNBC.com News
Healthy Returns: Novo Nordisk’s Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance
Tags Healthy Returns LILLY DRN Health & Science
From CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
Tags Pharmaceuticals Business News Biotechnology
From CNBC.com News
How much a $1,000 investment in Hims & Hers at its IPO would be worth now
Tags Novo Nordisk A/S Make It Hims & Hers Health Inc
From CNBC.com News
Hims & Hers brings former Amazon executive into C-suite
Tags Health & Science Breaking News: Technology Hims & Hers Health Inc
From CNBC.com News
Cramer's week ahead: Earnings from Disney, Palantir and Uber
Tags Wynn Resorts Ltd Walt Disney Co Mad Money
From CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Roche Holding AG
From CNBC.com News
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Business
From CNBC.com News
Novo Nordisk opens weight loss drug Wegovy to Hims & Hers, Ro and Life MD telehealth
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Business
From CNBC.com News
Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
Tags Business Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
Tags Pfizer Inc Elevance Health Inc Centene Corp
From CNBC.com News
5 European stocks to watch this earnings season as Trump's tariffs hit
Tickers OIL
Tags Europe Markets Markets Trade
From CNBC.com News
Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
Tags Biotechnology Health care industry Viking Therapeutics Inc
From CNBC.com News
CNBC Daily Open: Consumers are worried over the economy. The White House insists it’ll be fine
Tags Market Outlook UBS Group AG Morgan Stanley
From CNBC.com News
Pfizer scraps daily weight loss pill after liver injury in one patient
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Business
From CNBC.com News
Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback
Tags Luxury Breaking News: Politics Autos
From CNBC.com News
Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
Tags Biotechnology Health care industry Social issues
From CNBC.com News
The biggest winners and losers in Europe as Trump announces sweeping tariffs
Tags Novo Nordisk A/S World News Europe News
From CNBC.com News
Pharma tariff relief likely short-lived with sector-specific duties on the horizon
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Trade
From CNBC.com News
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
Tags Business Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
Tags Biotechnology Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.